eWireInformer -- Big US pharmaceutical companies are beginning to experience rising challenges in association with the FDA, the new health care reform laws and by generic drug companies. Within the past year, US pharmaceutical companies have cut more than 53,000 jobs to cut spending since the FDA has put these companies in the cross-hairs and are not approving as many drugs as they used to.
